1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
    Neuronal Signaling
  3. TRP Channel
  4. TRPV Isoform

TRPV

 

TRPV Related Products (22):

Cat. No. Product Name Effect Purity
  • HY-19608
    GSK1016790A
    Agonist 99.79%
    GSK1016790A is a potent and selective transient receptor potential vanilloid 4 (TRPV4) channel agonist.
  • HY-12245
    SB-366791
    Antagonist 98.72%
    SB-366791 is a potent and selective vanilloid receptor (VR1/TRPV1) antagonist (IC50=5.7 nM).
  • HY-N0361
    Dihydrocapsaicin
    Agonist 99.86%
    Dihydrocapsaicin, a capsaicin, is a potent and selective TRPV1 (transient receptor potential vanilloid channel 1) agonist.
  • HY-18662
    RQ-00203078
    Antagonist 99.84%
    RQ-00203078 is a highly selective, potent and orally active TRPM8 antagonist with IC50s of 5.3 nM and 8.3 nM for rat and human TRPM8 channels, respectively.
  • HY-107436
    LE135
    Activator 99.03%
    LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ.
  • HY-P1651A
    SOR-C13 TFA
    Antagonist 99.18%
    SOR-C13 TFA, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM.
  • HY-P1651
    SOR-C13
    Antagonist
    SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM.
  • HY-120294
    Chrysin 6-C-glucoside 8-C-arabinoside
    Inhibitor
    Chrysin 6-C-glucoside 8-C-arabinoside can inhibit the CGRP releasing and the activation of TRPV1 channel.
  • HY-100129
    JNJ-17203212
    Antagonist 99.94%
    JNJ-17203212 is a selective, potent and competitive TRPV1 antagonist.
  • HY-136363
    MDR-652
    Agonist 98.17%
    MDR-652 is a highly specific and efficacious transient receptor potential vanilloid 1 (TRPV1) ligand with agonist activity.
  • HY-114017
    Vanilloid receptor antagonist 1
    Antagonist 98.07%
    Vanilloid receptor antagonist 1 is a potent vanilloid receptor TRPV1 antagonist extracted from patent US8349852B2, compound B8.
  • HY-N8377
    Capsiate
    Agonist 99.51%
    Capsiate, as a capsaicin analogue extracted from a non-pungent cultivar of CH-19 sweet red pepper, is an orally active agonist of TRPV1.
  • HY-101323
    Olvanil
    Agonist ≥99.0%
    Olvanil (NE-19550) is an analgesic and an agonist of transient receptor potential vanilloid type 1 (TRPV1) channels with an EC50 of 0.7 nM.
  • HY-118785
    MSP-3
    Agonist 98.53%
    MSP-3 is a potent TRPV1 agonist, with an EC50 of 0.87 μM.
  • HY-19589
    JTS-653
    Antagonist
    JTS-653 is a highly potent and selective transient receptor potential vanilloid 1 (TRPV1) antagonist in vitro and in vivo.
  • HY-144372
    TRPV1 antagonist 3
    Antagonist
    TRPV1 antagonist 3 (Compound 7q) is a potent TRPV1 antagonist with an IC50 of 2.66 nM against capsaicin.
  • HY-P1175A
    L-R4W2 TFA
    Antagonist
    L-R4W2 TFA is a potent antagonist of vanilloid receptor 1 (VR1, TRPV1), with an IC50 of 0.1 μM.
  • HY-131868
    TRPV3 antagonist 74a
    Antagonist
    TRPV3 antagonist 74a is a potent and selective TRPV3 antagonist.
  • HY-P1175
    L-R4W2
    Antagonist
    L-R4W2 is a potent antagonist of vanilloid receptor 1 (VR1, TRPV1), with an IC50 of 0.1 μM.
  • HY-124073
    Dihydrocapsiate
    Agonist 99.18%
    Dihydrocapsiate, as a compound of capsinoid family, is an orally active TRPV1 agonist.